INSIGHTS ON DRUG DEVELOPMENT

• AI Based Screening And Selection Of Co-Formers For Co-Crystallization

  Explore how AI and quantum chemistry are accelerating co-crystal screening and solving solubility challenges in drug development, as well as key technical considerations for identifying optimal co-formers.

• Unlocking Robust Separations For Modern Peptide Therapeutics

  As peptide therapeutics grow more complex, impurity profiling demands greater chromatographic confidence. See how robust reproducibility can support reliable GLP-1 receptor agonist analysis.

• Eliminate Risk From Your Viral Vector Tech Transfers

  Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

• Are You Keeping Pace With Oligo Synthesis Optimization?

  The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.

• Cracking Complexity: Leveraging Lessons Learned For Future Bispecific Development

  8/14/2026

  The shift from static platforms to adaptive, knowledge-driven development helps biopharma teams manage BsAb complexity, accelerate analytical, purification, and formulation development, and improve IND readiness.

• Facts About AAV Producer Cell Lines

  8/8/2025

  Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.

• Sustainability In On-Body Delivery System Platforms

  7/2/2026

  Explore how our on-body delivery system supports high-volume biologic delivery by balancing usability, patient needs, and sustainability through research-driven design.

• AAV Downstream Challenges: Expert Insights

  5/22/2025

  Gain expert insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.

• Molecular Properties Of PROTACs And The Relationship To Formulation Design

  3/4/2025

  Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.